
Weekly 483 update
Aug 22, 2018 - 06:23
Radio and PodcastLive Radio & Podcasts
Valsartin API NDEA / NDMA contamination, MAPP 5014.1 Risk Based Site Selection Model. OSS 483 Inspection. Good Pharma Manufacturing covers many pharmaceutical topics from cGMP's, GDP's, compliance, training, drug recalls...
FDA 483, Mapp & News is an episode from Good Pharma Manufacturing : GMP FDA GDP 483 source. by Alan McPeck. Valsartin API NDEA / NDMA contamination, MAPP 5014.1 Risk Based Site Selection Model. OSS 483 Inspection. Good Pharma Manufacturing...
This episode belongs to Good Pharma Manufacturing : GMP FDA GDP 483 source..
Use the player on this page to stream the episode online.
Published Sep 17, 2018, 03:50 long, audio available.
Valsartin API NDEA / NDMA contamination, MAPP 5014.1 Risk Based Site Selection Model. OSS 483 Inspection. Good Pharma Manufacturing covers many pharmaceutical topics from cGMP's, GDP's, compliance, training, drug recalls, 483's, the history of the pharmaceutical industry, management, case studies and more.
You can listen to FDA 483, Mapp & News online on Radio and Podcast. Open the player on this page to stream the available audio.
FDA 483, Mapp & News is an episode from Good Pharma Manufacturing : GMP FDA GDP 483 source. by Alan McPeck.
This episode is 03:50 long.
This episode was published on Sep 17, 2018.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Good Pharma Manufacturing : GMP FDA GDP 483 source. when more episodes are available from the podcast feed.
You can listen to FDA 483, Mapp & News on this page when the episode audio is available from the podcast feed.
FDA 483, Mapp & News is from Good Pharma Manufacturing : GMP FDA GDP 483 source. by Alan McPeck.
Published Sep 17, 2018 and 03:50 long